It's well known that cancer patients are prone to losing weight during their treatment, but many people may not realize how weight loss that occurs prior to diagnosis can have a major impact on response to treatment.
A new Government Accountability Office report recommends sweeping government reforms that would mitigate fragmentation and duplication of a number of Medicare and Medicaid programs.
The Food and Drug Administration approved its first biosimilar product last week, opening the door for more costly drug alternatives.
It's not hard to see why the Ebola outbreak has so many of us on edge. It's sort of like the proverbial monster under the bed. Except this time, the monster is no figment of our imagination. And now it appears ready to pounce on us.
A terminally ill nursing home resident in Ohio has died after his son is alleged to have smothered him, according to police.
This is a very hard blog for me to write. My mother just passed away. It was very sudden and not expected. I am blessed to have two mothers: A step-mother who has been in my life since I have been 8 years old (the nurse I often speak of and call "Mom") and "Mother" who just passed. But the reason I am writing this is not to garner sympathy or share my pain, but to share a rare experience that I think only those of us in healthcare may understand.
One of the occupational hazards of being a journalist is that you often have to distribute bad news. But every so often you get to share something that's a bit more cheerful. This is one of those times.
The Food and Drug Administration is investigating a possible link between commonly prescribed diabetes drugs and pancreatic cancer. The drugs, including Januvia and Byetta, were previously connected with fatal cases of pancreatic inflammation known as pancreatitis.
It's not a secret that employees who work in healthcare, whether they are medical journalists or nurses, don't always earn gold stars when it comes to managing their own health. Witness the nurses clustering in a "butt hut" outside a facility, an administrator taking a cavalier approach to his or her diet, or saleswomen wearing sole-killing heels at a conference.
Comedienne Tig Notaro — from what I've been able to glean in my relatively brief history as a fan of her comedy — does not appear to have any connection with the long-term care industry. But in listening to her now famous standup act that announced her diagnosis of breast cancer, I had a feeling many in the LTC field would welcome her as one of their own.
If seniors have to pay a higher portion of their medical costs, it could lead to their financial ruin, especially if they have dementia, a study asserts.
The Obama administration has said it will devote $50 million to fund Alzheimer's research this year, and an additional $80 million in 2013.
Medicare should reimburse for medical nutrition therapy (MNT) — or consultations with a registered dietician — to prevent and treat chronic health conditions such as hypertension, obesity, cancer and renal disease.
The number of cancer survivors over the age of 65 is expected to increase by about 42% over the next 10 years, which could present new challenges to the healthcare community, study results show.
Those of us who were fortunate enough to work alongside Dr. Paul Willging quickly learned of the depth of his commitment to long-term care and to those people who dedicate their lives to providing such care.
One of the realities of the national budget crisis is that government funding for age-related health conditions — particularly Alzheimer's — is drying up, says a new report from the Alzheimer's Foundation of America.
The first rule of any debate, or "heated" discussion, is to know your definitions. If you don't, not much else matters. With caregiving, it comes down to knowing your people.
The Centers for Medicare & Medicaid Services on Tuesday ended its contract with Fox Insurance Company after an on-site review revealed serious policy violations. It represents the first time that CMS has terminated a contract with a Part D drug plan since the drug program began in 2006, according to CMS.